Literature DB >> 16061601

Effect of obesity and high blood pressure on plasma lipid levels in children and adolescents.

Gillian S Boyd1, Joanna Koenigsberg, Bonita Falkner, Samuel Gidding, Sandra Hassink.   

Abstract

OBJECTIVE: To examine the extent of blood lipid abnormalities in overweight children and to determine whether the prevalence of dyslipidemia is different in overweight children with elevated blood pressure (BP) compared with overweight children with normal BP (NBP).
METHODS: A retrospective, case-control study on 497 patients 2 to 18 years of age at the Nemours Weight Management Clinic of duPont Hospital for Children was conducted to compare the prevalence of abnormal plasma lipid levels in overweight children with high BP with overweight children with NBP.
RESULTS: Elevated BP was detected in 34.7% of the sample; 27.9% had prehypertension (pre-HTN), and 6.8% had HTN. The rates of abnormal plasma lipid levels were high among overweight children with both NBP and HTN. Significantly more boys with high BP had low high-density lipoprotein cholesterol compared with boys with NBP (49.4% vs 27.6%). Significantly more severely obese boys had low high-density lipoprotein cholesterol compared with moderately obese boys (40.3% vs 29.3%). The prevalence of elevated BP was much greater in severely obese boys and girls (46.5% and 39%) than moderately obese boys and girls (28.1% and 23.1%).
CONCLUSIONS: The high prevalence of dyslipidemia found in this overweight sample supports recent recommendations to collect plasma lipid levels in not only overweight children with BP > or =90th percentile but also in all overweight children.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061601     DOI: 10.1542/peds.2004-1877

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  25 in total

1.  Deacetylation by SIRT1 Reprograms Inflammation and Cancer.

Authors:  Tie Fu Liu; Charles E McCall
Journal:  Genes Cancer       Date:  2013-03

2.  Risk profiles for metabolic syndrome in a nonclinical sample of adolescent girls.

Authors:  Alison K Ventura; Eric Loken; Leann L Birch
Journal:  Pediatrics       Date:  2006-12       Impact factor: 7.124

3.  Cardiovascular Risk in Children and Adolescents with Type 1 and Type 2 Diabetes Mellitus.

Authors:  Sheela N Magge
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-09-25

4.  Casual blood pressure of adolescents attending public secondary schools in Maiduguri, Nigeria.

Authors:  Adetoyeje Y Oyeyemi; Muhammad A Usman; Adewale L Oyeyemi; Olabode A Jaiyeola
Journal:  Clin Hypertens       Date:  2015-09-03

5.  Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1.

Authors:  Lina Basel-Vanagaite; Noam Zevit; Adi Har Zahav; Liang Guo; Saj Parathath; Metsada Pasmanik-Chor; Adam D McIntyre; Jian Wang; Adi Albin-Kaplanski; Corina Hartman; Daphna Marom; Avraham Zeharia; Abir Badir; Oded Shoerman; Amos J Simon; Gideon Rechavi; Mordechai Shohat; Robert A Hegele; Edward A Fisher; Raanan Shamir
Journal:  Am J Hum Genet       Date:  2012-01-05       Impact factor: 11.025

Review 6.  Prevalence of metabolic syndrome and obesity-associated hypertension in the racial ethnic minorities of the United States.

Authors:  Bonita Falkner; Nicole D F H Cossrow
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

Review 7.  Antihypertensive properties of plant-based prebiotics.

Authors:  Siok-Koon Yeo; Lay-Gaik Ooi; Ting-Jin Lim; Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2009-08-10       Impact factor: 6.208

8.  Prehypertension and hypertension in community-based pediatric practice.

Authors:  Joan C Lo; Alan Sinaiko; Malini Chandra; Matthew F Daley; Louise C Greenspan; Emily D Parker; Elyse O Kharbanda; Karen L Margolis; Kenneth Adams; Ronald Prineas; David Magid; Patrick J O'Connor
Journal:  Pediatrics       Date:  2013-01-28       Impact factor: 7.124

9.  Diet intervention on obese children with hypertension in China.

Authors:  Yan-Ping Wan; Ren-Ying Xu; Ying-Jie Wu; Zhi-Qi Chen; Wei Cai
Journal:  World J Pediatr       Date:  2009-11-13       Impact factor: 2.764

10.  Dyslipidemia in Iranian overweight and obese children.

Authors:  Robabeh Ghergerehchi
Journal:  Ther Clin Risk Manag       Date:  2009-09-24       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.